Skip to main content

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

Publication ,  Journal Article
Schmitz, R; Manook, M; Fitch, Z; Anwar, I; DeLaura, I; Olaso, D; Choi, A; Yoon, J; Bae, Y; Song, M; Farris, AB; Kwun, J; Knechtle, S
Published in: Frontiers in transplantation
January 2023

Duke Scholars

Published In

Frontiers in transplantation

EISSN

2813-2440

ISSN

2813-2440

Publication Date

January 2023

Volume

2
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schmitz, R., Manook, M., Fitch, Z., Anwar, I., DeLaura, I., Olaso, D., … Knechtle, S. (2023). Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model. Frontiers in Transplantation, 2.
Schmitz, Robin, Miriam Manook, Zachary Fitch, Imran Anwar, Isabel DeLaura, Danae Olaso, Ashley Choi, et al. “Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model.” Frontiers in Transplantation 2 (January 2023).
Schmitz R, Manook M, Fitch Z, Anwar I, DeLaura I, Olaso D, et al. Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model. Frontiers in transplantation. 2023 Jan;2.
Schmitz R, Manook M, Fitch Z, Anwar I, DeLaura I, Olaso D, Choi A, Yoon J, Bae Y, Song M, Farris AB, Kwun J, Knechtle S. Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model. Frontiers in transplantation. 2023 Jan;2.

Published In

Frontiers in transplantation

EISSN

2813-2440

ISSN

2813-2440

Publication Date

January 2023

Volume

2